Member Info for draft

paid over 1p lol

if Tr1s lands be interesting if this rebounds to 1p

and offices

just went over 400p

the concentration of antibody is key

500p easy

only 9.15am - early doors yet

3.52%
Forum Venture Capital GmbH 6,936,188 24.67%
Axxion SA 2,795,252 9.94%
Frankfurter Investmentgesellschaft mit variablem Kapital (SICAV) 2,419,648 8.61%
Schroders plc 3,267,802 11.62%
Polar Capital European Forager Fund Ltd 1,143,572 4.07%
Shareholder Value Beteiligungen AG 1,645,000 5.85%
TOTAL 64.76%

novacyte 170mill
avacta 295mill

which other test kit company was using Eliza?? Its made by IDH.

Manufacturing Support
As the world struggles to contain the novel coronavirus (COVID-19) outbreak, it becomes clear that diagnostics test availability is a key constraint. To support our healthcare systems with this challenge, we need to rapidly move production resources into this area.
We at Immunodiagnostic Systems (IDS) want to play a part in the global effort fighting this pandemic. Therefore, we would like to offer our expertise and support in manufacturing ELISA kits for those companies with a COVID-19 diagnostic test that need more production capacity.
What we can provide
IDS is a leading in vitro diagnostic solution provider to the clinical laboratory market. We develop, manufacture and market innovative immunoassays and automated immunoanalyser technologies to provide improved diagnostic outcomes for patients.
We can offer large scale ELISA plate production, from initial formulation to packaging, labelling and shipment in our ISO 13485 and cGMP qualified facilities in Italy and the United Kingdom.

hopefully see 400 or 500p today

Jaap Stuut, CEO of IDS commented
"We are pleased that our collaboration with Technogenetics has achieved the important milestone of CE-marking a quantitative, fully automated SARS-CoV-2 antibody test running on the IDS-iSYS analyser. We anticipate launching this assay throughout Europe later this month. IDS has increased production levels of its analysers, and we have sufficient inventory levels to facilitate higher analyser placement levels driven by new customers wishing to run the Test."

off the radar! Immunodiagnostic Systems Holdings plc (IDS), a specialty solution provider to the clinical laboratory diagnostic market, announces a new automated COVID-19 IgG assay (The Test) has achieved CE marking and is expected to be available for sale by the end of this month.
The Test, which arises from the partnership between IDS and Technogenetics, is designed to run on the automated IDS-iSYS analyser. Today IDS and Technogenetics reached a commercial agreement under which IDS shall sell, market and support this Test on a global basis. For territories which do not accept CE marked products, the requisite regulatory approvals will be required.

Significant Shareholders
Company Name
Number of ordinary shares of 2p each
Percentage of issued share capital
Forum European Smallcaps GmbH
989,876
3.52%
Forum Venture Capital GmbH
6,936,188
24.67%
Axxion SA
2,795,252
9.94%
Frankfurter Investmentgesellschaft mit variablem Kapital (SICAV)
2,419,648
8.61%
Schroders plc
3,267,802
11.62%
Polar Capital European Forager Fund Ltd
1,143,572
4.07%
Shareholder Value Beteiligungen AG
1,645,000
5.85%

70% of the shares are tightly held here

could really do another 100% today - antibodies test kits

yesterday - store reopening rns today

forget the broker targets - pointless

bought at 50p plus, my worst buy in ages - FFS

is confident

should bounce when those TR1s land

no point talking about trice - more worth talking about what Parsely Shell ex, will do
and no point talking about fantasy takeovers
this is a binary play in the short term - she increases production more or not